Caulis, Inc. (153A) AI Stock Analysis

• Market Cap: ¥6.84B
• Dividend Yield: N/A
• Average Volume (3M): 92.42K
• Price to Earnings (P/E): 24.4
• Beta (1Y): 1.37
• Revenue Growth: 14.92%
• EPS Growth: 2.55%
• Country: JP
• Employees: 42
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 8.88
• Shares Outstanding: 6,528,000
• 10 Day Avg. Volume: 64,850
• 30 Day Avg. Volume: 92,423
• PEG Ratio: -7.19
• Price to Book (P/B): 4.57
• Price to Sales (P/S): 5.41
• P/FCF Ratio: 36.86
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 66 Neutral
• Price Target: ¥1,241.00 ▼(-41.71% Downside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is driven primarily by strong financial performance (rapid growth, solid profitability, and improved leverage), offset by weak technicals (price below all key moving averages and negative MACD) and only moderate valuation support given a 30.21 P/E and low (~0.42%) dividend yield.

Positive Factors

Revenue and margin expansion

A large revenue step-up in 2025 combined with high gross and operating margins indicates the business can scale while maintaining strong unit economics. Durable margins and rapid top-line growth support reinvestment for product development and distribution expansion over the next several quarters.

Materially improved leverage and returns

A very low debt-to-equity ratio and healthy ROE improve financial flexibility, lowering insolvency risk and enabling funded R&D, partnerships, or selective M&A. Strong equity growth and conservative leverage support operational resilience through industry cycles over the medium term.

Cash-supported earnings

FCF tracking reported net income so closely signals high earnings quality and cash-conversion potential. That alignment supports sustainable investment in commercialization, steady working-capital needs, and the ability to fund collaborations or licensing without immediate external financing.

Negative Factors

Margin compression versus prior years

Compression from previously higher gross and net margins suggests rising input costs, pricing pressure, or less favorable product mix as the company scales. Persisting margin erosion could weaken free cash generation and limit room for sustained R&D or distributor incentives over coming quarters.

Operating cash flow decline and FCF volatility

Despite profitable income, declining operating cash flow and falling FCF indicate variability in cash conversion. This volatility constrains the company's ability to consistently self-fund growth initiatives and raises funding risk if margins or revenue momentum soften over a multi-quarter horizon.

Recentness of financial recovery

Historical negative equity and former high leverage mean current strength is relatively recent, so sustainability is unproven. If growth slows or cash volatility persists, the company may face financing or governance pressures that expose residual balance-sheet fragility.

Caulis, Inc. Business Overview & Revenue Model

Company Description

Caulis, Inc. (153A) is a biotechnology company specializing in the development of innovative agricultural solutions and biopesticides aimed at enhancing crop productivity and sustainability. The company focuses on harnessing natural plant-based compounds and advanced biotechnological methods to create products that protect crops from pests and diseases while minimizing environmental impact. Caulis, Inc. operates primarily within the agricultural sector, catering to farmers and agricultural businesses seeking eco-friendly alternatives to traditional chemical pesticides.

How the Company Makes Money

Caulis, Inc. generates revenue through multiple key streams, primarily from the sale of its biopesticide products to agricultural distributors and directly to farmers. The company also engages in research and development collaborations with agricultural firms and universities, which can lead to sponsored research agreements and licensing deals for its proprietary technologies. Additionally, Caulis, Inc. may receive grants and funding from government and non-governmental organizations focused on sustainable agriculture initiatives. Strategic partnerships with larger agricultural companies enhance its market reach and distribution capabilities, contributing significantly to its earnings.

Caulis, Inc. Financial Statement Overview

Summary

Strong fundamentals: sharp revenue acceleration in 2025 (~108.9%) with robust profitability (gross margin ~58%, operating margin ~29%, net margin ~20%) and a materially improved balance sheet (debt-to-equity ~0.06; healthy ROE ~16.7%–21.0%). Key offsets are margin compression versus 2022–2024 and softer/volatile operating cash flow with lower cash conversion in 2025.

Income Statement

The company shows strong scale-up and profitability. Revenue accelerated sharply in 2025 (annual revenue growth of ~108.9%) after solid growth in 2022–2024, indicating strong demand/momentum. Profitability is robust for the sector, with 2025 gross margin ~58% and operating margin ~29%, and net margin near ~20%. The main weakness is margin compression versus prior years (gross and net margins were higher in 2022–2024), suggesting higher costs or pricing pressure as the business scales.

Balance Sheet

Leverage has improved materially, with debt-to-equity dropping from elevated levels in 2022–2023 to very low in 2025 (~0.06), alongside meaningful equity growth. Returns on equity are healthy in 2024–2025 (~16.7%–21.0%), supporting capital efficiency. Key risk: earlier periods included negative equity (2021) and high leverage (2022), so while the balance sheet is much stronger now, investors should view the improvement as relatively recent and monitor sustainability.

Cash Flow

Cash generation is solid: free cash flow closely tracks net income across years (roughly ~98%–100%), suggesting reported earnings are largely supported by cash. However, operating cash flow declined in 2025 versus 2024 (despite higher revenue), and cash conversion from earnings is moderate based on the provided operating-cash-flow-to-net-income figure (about ~0.40–0.64 historically, ~0.40 in 2025). Free cash flow also fell in 2024 and again in 2025, indicating some volatility in cash production even as profitability remains strong.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	670.56M	1.40B	1.23B	995.00M	769.47M	489.21M
Gross Profit	422.33M	817.28M	774.96M	613.46M	495.40M	254.37M
EBITDA	225.14M	415.15M	394.62M	302.29M	225.93M	20.00M
Net Income	145.63M	276.44M	276.30M	260.37M	249.96M	13.46M
Balance Sheet
Total Assets	2.21B	2.18B	2.02B	1.18B	718.30M	481.51M
Cash, Cash Equivalents and Short-Term Investments	1.88B	1.49B	1.73B	954.70M	604.11M	431.24M
Total Debt	250.00M	100.00M	250.00M	301.00M	250.00M	290.00M
Total Liabilities	745.17M	525.67M	708.52M	727.04M	527.01M	538.44M
Stockholders Equity	1.47B	1.66B	1.32B	451.66M	191.28M	-56.93M
Cash Flow
Free Cash Flow	0.00	205.42M	265.90M	299.58M	212.86M	117.33M
Operating Cash Flow	0.00	208.97M	266.22M	306.55M	215.42M	119.36M
Investing Cash Flow	0.00	-373.80M	-322.00K	-6.95M	-2.56M	-2.02M
Financing Cash Flow	0.00	-81.20M	512.50M	51.00M	-40.00M	-2.50M

Caulis, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2129.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:153A, the sentiment is Negative. The current price of 2129 is above the 20-day moving average (MA) of 1166.25, above the 50-day MA of 1195.32, and above the 200-day MA of 1694.57, indicating a bearish trend. The MACD of -38.31 indicates Positive momentum. The RSI at 41.35 is Neutral, neither overbought nor oversold. The STOCH value of 13.16 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:153A.

Caulis, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4060	74 Outperform	¥6.53B	23.92	―	0.57%	21.03%	32.29%
4397	68 Neutral	¥6.94B	17.25	―	―	11.32%	―
4168	67 Neutral	¥8.77B	9.39	―	0.70%	9.78%	-23.98%
153A	66 Neutral	¥6.84B	24.43	―	―	14.92%	2.55%
5033	66 Neutral	¥4.80B	13.11	―	―	7.60%	19.13%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
4484	55 Neutral	¥5.07B	25.77	―	―	4.36%	-0.02%